Unicycive Therapeutics In... (UNCY)
0.64
-0.02 (-3.19%)
At close: Jan 15, 2025, 12:04 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -30.54M | -18.06M | -10.02M | -2.26M | -2.17M | -1.12M |
| Depreciation & Amortization | 284.00K | 161.00K | 13.00K | n/a | n/a | n/a |
| Stock-Based Compensation | 1.77M | 1.05M | 966.00K | 232.00K | 24.00K | n/a |
| Other Working Capital | -1.37M | -89.00K | -1.35M | -98.00K | -3.00K | -25.00K |
| Other Non-Cash Items | 10.30M | 21.00K | 3.25M | 739.00K | 660.00K | 308.00K |
| Deferred Income Tax | n/a | n/a | 127.00K | n/a | n/a | n/a |
| Change in Working Capital | -93.00K | 1.18M | -105.00K | -166.00K | 305.00K | 6.00K |
| Operating Cash Flow | -18.28M | -15.65M | -5.77M | -1.46M | -1.18M | -775.00K |
| Capital Expenditures | -12.00K | -2.00K | -29.00K | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -12.00K | -2.00K | -29.00K | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 1.42M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 27.54M | -482.00K | 22.38M | -117.00K | 1.17M | 800.00K |
| Financial Cash Flow | 27.54M | -471.00K | 22.38M | 1.44M | 1.17M | 800.00K |
| Net Cash Flow | 9.25M | -16.12M | 16.58M | -15.00K | -10.00K | 25.00K |
| Free Cash Flow | -18.30M | -15.65M | -5.80M | -1.46M | -1.18M | -775.00K |